Monday, October 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 10, 2026

Teradata Reports Fourth Quarter and Full-Year 2025 Financial Results

View original at finance.yahoo.com
Teradata Reports Fourth Quarter and Full-Year 2025 Financial Results Fourth quarter Total ARR of $1.522 billion, an increase of 3% as reported and 1% in constant currency from the prior year period(1) Fourth quarter Recurring Revenue of $367 million, up 5% as reported and 3% in constant currency(1) Fourth quarter GAAP…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Our full-year results demonstrate strong operational discipline and establish a solid foundation as we enter 2026

    80% confidence

  • We have confidence in our agentic AI-fueled future

    80% confidence

  • Total ARR growth expected to be 2% to 4% year-over-year for full-year 2026

    80% confidence

  • Recurring revenue expected in the range of 6% to 8% year-over-year for Q1 2026

    80% confidence

  • Teradata's Autonomous AI and Knowledge platform is soundly resonating with customers; they recognize that the strengths we have built over decades are ideal for today's market needs

    80% confidence

  • Non-GAAP diluted EPS expected to be in the range of $2.55 to $2.65 per share for full-year 2026

    80% confidence

  • Free cash flow expected to be $310 million to $330 million for full-year 2026

    80% confidence

  • Our differentiated performance, scale, and hybrid capabilities, supported by our AI services, are proving to be a valuable combination

    80% confidence

  • Teradata delivered another set of strong results in the 4th quarter, as we again exceeded expectations for Total Revenue, Recurring Revenue and Free Cash Flow

    80% confidence

  • Recurring revenue expected in the range of flat to 2% year-over-year for full-year 2026

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com